Dr. Ashiq Ali, Shantou University Medical College, China
Dr. Ashiq Ali is a dedicated postdoctoral fellow at Shantou University Medical College, China, with a strong academic background in Pathology and Immunology. He earned his Ph.D. in Pathology and Immunology from the University of Agriculture Faisalabad. With expertise in cancer epigenetics, immunoproteomics, and molecular diagnostics, he has significantly contributed to vaccine development and probiotic research. His commitment to advancing scientific knowledge is evident through numerous publications and successful research projects. As a passionate educator, Dr. Ali has experience mentoring students and conducting lectures on pathology and clinical diagnostics. His dedication to innovative research and academic excellence makes him a valuable contributor to the global scientific community. ππ¬π§¬
Publication Profile
Google Scholar
Education π
Dr. Ashiq Ali pursued his Ph.D. in Pathology and Immunology (2017β2022) from the University of Agriculture Faisalabad, focusing on cancer epigenetics and immunoproteomics. Prior to that, he completed his M.Phil. in Pathology (2014β2016) at the same university, excelling in clinical diagnostics and molecular biology. His academic journey began with a Doctor of Veterinary Medicine (DVM) (2009β2014), where he developed a strong foundation in veterinary pathology, microbiology, and immunology. Throughout his education, Dr. Ali demonstrated exceptional dedication, earning prestigious scholarships and excelling in his research pursuits. His continuous pursuit of knowledge in pathological research and immunological studies highlights his commitment to contributing to the medical and scientific fields. ππ§βπ¬π
Experience πΌ
Dr. Ashiq Ali is currently a postdoctoral fellow at Shantou University Medical College, China, conducting advanced research in pathology and immunology. From 2018 to 2019, he served as a Teaching Assistant at the University of Agriculture Faisalabad, where he conducted practical and theoretical classes on subjects like General Pathology, Clinical Pathology, and Oncology. Between 2016 and 2020, he contributed as a volunteer research assistant, gaining extensive hands-on experience in molecular diagnostics, PCR, immunohistochemistry, and virus cultivation. His role involved supervising laboratory operations, mentoring students, and conducting detailed investigations into infectious diseases, cancer research, and vaccine development. Dr. Aliβs dynamic experience across teaching, research, and lab management highlights his versatility and dedication to scientific advancements. π§ͺππ
Awards and Honors π
Dr. Ashiq Aliβs academic excellence has been recognized through prestigious awards, including a Merit Scholarship during his M.Phil. in Pathology at the University of Agriculture Faisalabad (2014β2016). His exceptional research capabilities earned him the Indigenous Ph.D. Fellowship from the Higher Education Commission (HEC) of Pakistan (2018β2022), supporting his groundbreaking work in cancer epigenetics and immunology. These accolades underscore his academic dedication, research competence, and commitment to scientific growth. His contributions have not only elevated his academic standing but also significantly advanced the field of pathology and immunology. π
ππ§βπ¬
Research Focus π§¬
Dr. Ashiq Ali’s research centers on cancer epigenetics, immunoproteomics, and molecular diagnostics, with a keen interest in tumor identification, immunohistochemistry, and gene expression analysis. His expertise includes the development of vaccines using plant-based adjuvants, investigating the therapeutic potential of interferon-alpha against viruses, and applying probiotics for mycotoxin biodegradation. Additionally, Dr. Ali explores the role of pathological markers in disease diagnosis and studies the effects of environmental toxins. His research contributions, particularly in advancing molecular and cellular pathology, continue to pave the way for innovative treatments in infectious diseases, oncology, and veterinary medicine. π§«π§ͺπ§βπ¬
Publication Top Notes
-
π Microbial and enzymatic battle with food contaminant zearalenone (ZEN) – Cited by: 23 – Year: 2022
-
π In-vitro assessment of a novel plant rhizobacterium, Citrobacter freundii, for degrading and biocontrol of food mycotoxin deoxynivalenol – Cited by: 21 – Year: 2023
-
π Prevalence, molecular characterization and antibiogram study of Listeria monocytogenes isolated from raw milk and milk products – Cited by: 18 – Year: 2020
-
π Probiotics: Helpful for the prevention of COVID-19? – Cited by: 17 – Year: 2020
-
π Green nanotechnology mediated silver and iron oxide nanoparticles: Potential antimicrobials – Cited by: 15 – Year: 2022
-
π Type I IFNs: a blessing in disguise or partner in crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-induced pathology and potential use of type I IFNs in synergism with IFN-Ξ³ – Cited by: 14 – Year: 2021
-
π Potassium use efficiency of maize hybrids – Cited by: 12 – Year: 2012
-
π Aflatoxins associated oxidative stress and immunological alterations are mitigated by dietary supplementation of Pichia kudriavzevii in broiler chicks – Cited by: 10 – Year: 2021
-
π Reply Letter-COVID-19 (Novel Coronavirus 2019)-Recent trends – Cited by: 10 – Year: 2020
-
π Potential therapeutic strategies to combat HCC – Cited by: 9 – Year: 2022
-
π Role of Streptococci as etiological agents of dental caries – Cited by: 9 – Year: 2020
-
π Pollen micromorphology among amaranthaceous species from desert rangeland – Cited by: 8 – Year: 2023
-
π Impact of silver dopant on structural, optical and electrical properties of ZnO nanoparticles – Cited by: 8 – Year: 2019
-
π The adverse effects of carbofuran are efficiently counteracted by the supplementation of star anise (Illicium verum) in broiler chicks – Cited by: 7 – Year: 2020
-
π Mitigative Potential of Novel Lactobacillus plantarum TISTR 2076 against the Aflatoxins-Associated Oxidative Stress and Histopathological Alterations in Liver and Kidney of Broiler Chicks – Cited by: 6 – Year: 2022
Conclusion
Dr. Ashiq Ali’s strong academic background, extensive research experience, and high-impact contributions in pathology and immunology make him a strong candidate for the Best Researcher Award. His expertise in molecular diagnostics, vaccine development, and immunology, coupled with his teaching and mentoring skills, align well with the awardβs criteria.